Vaping reforms
From 1 July 2024 the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 has changed the way vapes can be sourced, supplied and advertised.
From 1 October 2024 pharmacists will be able to supply vapes with a nicotine concentration of 20 mg/mL or less, to people 18 years or over without a prescription subject to certain conditions and state and territory law.
Ask, Advise, Help: Starting a conversation with your patients
Ask, Advise, Help is a quick way for health professionals to form the basic structure for brief advice on smoking cessation care.
E-cigarette use and respiratory symptoms
A prospective study examined e-cigarette use and respiratory symptoms in adolescents and young adults.
Updated Clinical Resources in Pregnancy and Breastfeeding
Smoking is the most common preventable risk factor for pregnancy complications.
Pharmaceutical Society of Australia – Professional practice guidelines: nicotine dependence support
The PSA has released new practice guidelines which provide advice to pharmacists when providing smoking cessation support.
RACGP Guidelines - Supporting smoking & vaping cessation: A guide for health professionals
Guidance on smoking and vaping cessation support related to changes to Australia's vaping regulations, as of 1 October 2024.
Quit Centre Quarterly Newsletter - September 2024
Read our spring issue of Quit Centre Quarterly.
New training module: Pharmacists delivering nicotine dependence treatment under vaping reforms
The ‘Pharmacists delivering nicotine dependence treatment under vaping reforms’ online training module is designed to support pharmacists on the new regulatory framework introduced by the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024.
Cytisine for cessation
A final decision has been made on proposed amendments to the Poisons Schedule in relation to cytisine. The delegate of the Secretary of the Department of Health and Aged Care (the Delegate) made the decision to create new entries for cytisine in Schedules 3 and 4 and Appendix H. Currently there are no cytisine products on the Australian Register of Therapeutic Goods.
The role of nurses in smoking cessation interventions for patients
A newly published review highlights the critical role nurses play in smoking cessation interventions. Analysis of 53 articles indicated that nurses commonly engaged in smoking assessment with patients, but it was not common for nurses to receive training in smoking cessation interventions. Smoking cessation training will enable nurses to deliver effective smoking cessation interventions with patients.